NewsDialy
A bipartisan group of Congressional lawmakers has written to Health and Human Services Secretary Robert F.
Kennedy Jr., pressing the Trump administration to compel Eli Lilly to restore federally mandated price breaks to hospitals enrolled in the 340B drug discount program.
Lilly cut off those discounts last month to roughly 50 larger hospital systems that had refused to hand over claims data the drugmaker now requires as a condition of participation.
What the 340B Program Is — and What's at Stake The 340B program is a federal drug discount program that requires pharmaceutical manufacturers to sell medicines at reduced prices to qualifying hospitals.
Keep reading